(R)-N-((S)-1-(2-(Dicyclohexylphosphanyl)phenyl)ethyl)-N,2-dimethylpropane-2-sulfinamide

Catalog No. :
ACMGPE538
CAS No. :
2253984-97-1
Molecular Formula :
C25H42NOPS
Molecular Weight :
435.66

IUPAC Name:(R)-N-((S)-1-(2-(dicyclohexylphosphaneyl)phenyl)ethyl)-N,2-dimethylpropane-2-sulfinamide

(R)-N-((S)-1-(2-(Dicyclohexylphosphanyl)phenyl)ethyl)-N,2-dimethylpropane-2-sulfinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg95%$137.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-N-((S)-1-(2-(Dicyclohexylphosphanyl)phenyl)ethyl)-N,2-dimethylpropane-2-sulfinamide
IUPAC Name(R)-N-((S)-1-(2-(dicyclohexylphosphaneyl)phenyl)ethyl)-N,2-dimethylpropane-2-sulfinamide
MDL No.MFCD33401781
Molecular FormulaC25H42NOPS
Molecular Weight435.66
SMILESCC([S@](N([C@H](C1=CC=CC=C1P(C2CCCCC2)C3CCCCC3)C)C)=O)(C)C
InChI KeyDBEGJDQBKCWIDZ-AFJIDDCJSA-N
Synonym(R)-N-[(S)-1-[2-(Dicyclohexylphosphino)phenyl]ethyl]-N,2-dimethylpropane-2-sulfinamide
CAS No.2253984-97-1
PubChem CID156620884

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACMGPE538 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMGPE538 route product structure diagram
    ACMGPE5382253984-97-1
Inquiry

2. ACMGPE538 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMGPE538 route product structure diagram
    ACMGPE5382253984-97-1
Inquiry

Comments (0)